Antiviral activity of on HSV-1, 2 .

Javad Charostad, Tahere Navidfar, Masoumeh Kiani, Paul Schinitzler, Akram Astani
Author Information
  1. Javad Charostad: Department of Microbiology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  2. Tahere Navidfar: Department of Basic Sciences, Shoushtar Faculty of Medical Sciences, Shushtar University of Medical and Science, Shushtar, Iran.
  3. Masoumeh Kiani: Department of Microbiology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  4. Paul Schinitzler: Department of Infectious Diseases, Virology, University of Heidelberg, Heidelberg, Germany.
  5. Akram Astani: Department of Microbiology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Abstract

Background and Objectives: Medicinal plants are the primary treatment for many infectious and non-infectious diseases. In this study, we evaluated the antiviral activity of against herpes simplex viruses 1 and 2, and compared it with the antiviral drug acyclovir.
Materials and Methods: In our experimental study, was dissolved in DMSO, then diluted in DMEM medium. Acyclovir was used at a concentration of 100 μM in all procedures. The antiherpetic activity and Antiviral activity of were evaluated in Vero cells (African green monkey kidney cells) by using the plaque reduction assay.
Results: Inhibitory concentrations of 50% (IC) of for HSV-1 and HSV-2 were determined at 0.00025% and 0.00015%, respectively. was introduced at various stages of viral infection and significantly inhibited HSV-1 and HSV-2 infectivity by > 95.5% and 89%, respectively, when virus was pre-treated before addition to the cells. No HSV-1 or HSV-2 activity was detected in cells treated prior to and following viral infection.
Conclusion: These results indicate that demonstrates antiherpetic activity in the early phase of viral infection and could be used as potential antiviral agent.

Keywords

References

  1. Toxicol Mech Methods. 2020 Jan;30(1):1-18 [PMID: 31409172]
  2. J Nat Prod. 2009 Sep;72(9):1568-72 [PMID: 19691312]
  3. Phytomedicine. 2008 Jan;15(1-2):71-8 [PMID: 17976968]
  4. Pharmacogn Rev. 2012 Jul;6(12):141-6 [PMID: 23055640]
  5. Antimicrob Agents Chemother. 2002 Jun;46(6):1870-4 [PMID: 12019102]
  6. Forsch Komplementmed. 2009 Apr;16(2):79-90 [PMID: 19420953]
  7. Phytomedicine. 2014 Sep 25;21(11):1273-80 [PMID: 25172789]
  8. Phytochemistry. 2000 Mar;53(6):689-97 [PMID: 10746882]
  9. J Food Sci Technol. 2021 Jun;58(6):2148-2159 [PMID: 33967312]
  10. Curr Med Chem. 2020;27(24):4118-4137 [PMID: 29521211]
  11. J Pharm Pharmacol. 2008 Nov;60(11):1545-50 [PMID: 18957177]
  12. Int J Pharm. 2020 Sep 25;587:119676 [PMID: 32738458]
  13. Avicenna J Phytomed. 2020 Jul-Aug;10(4):407-416 [PMID: 32850297]
  14. Food Chem Toxicol. 2020 Jun;140:111312 [PMID: 32247803]
  15. BMC Infect Dis. 2020 Oct 20;20(1):782 [PMID: 33081701]
  16. Antimicrob Agents Chemother. 2020 Nov 17;64(12): [PMID: 32988829]
  17. Avicenna J Phytomed. 2018 Jul-Aug;8(4):296-312 [PMID: 30377589]
  18. World J Biol Chem. 2023 Mar 27;14(2):28-39 [PMID: 37034135]
  19. Phytother Res. 2014 Oct;28(10):1547-52 [PMID: 24817544]
  20. Mikrobiyol Bul. 2020 Jan;54(1):79-94 [PMID: 32050880]
  21. Nat Prod Res. 2016;30(3):350-3 [PMID: 26134757]
  22. Iran J Pharm Res. 2014 Spring;13(2):523-30 [PMID: 25237347]
  23. J Clin Virol. 2020 Jul;128:104421 [PMID: 32417677]
  24. J Med Chem. 2008 Feb 28;51(4):842-51 [PMID: 18247552]
  25. J Ethnopharmacol. 2011 Mar 8;134(1):1-10 [PMID: 21130854]
  26. Phytomedicine. 2008 Sep;15(9):734-40 [PMID: 18693101]

Word Cloud

Created with Highcharts 10.0.0activitycellsHSV-1antiviralsimplex2AntiviralHSV-2viralinfectionvirusstudyevaluated1usedantiherpetic0respectivelyHerpestypeBackgroundObjectives:Medicinalplantsprimarytreatmentmanyinfectiousnon-infectiousdiseasesherpesvirusescompareddrugacyclovirMaterialsMethods:experimentaldissolvedDMSOdilutedDMEMmediumAcyclovirconcentration100μMproceduresVeroAfricangreenmonkeykidneyusingplaquereductionassayResults:Inhibitoryconcentrations50%ICdetermined00025%00015%introducedvariousstagessignificantlyinhibitedinfectivity>955%89%pre-treatedadditiondetectedtreatedpriorfollowingConclusion:resultsindicatedemonstratesearlyphasepotentialagentFerulaassa-foetida

Similar Articles

Cited By

No available data.